Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study ...
The MarketWatch News Department was not involved in the creation of this content. Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant ...
Booster Therapeutics is developing a novel therapeutic approach that aims to combat the accumulation of deviant proteins in cells, which are a major driver of Parkinson’s and other complex diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback